Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.85 USD | +3.36% |
|
+33.09% | +51.31% |
Jul. 02 | Avid Bioservices Fiscal Q4 Loss Widens, Revenue Increases; Fiscal 2025 Revenue Outlook Set | MT |
Jul. 02 | Transcript : Avid Bioservices, Inc., Q4 2024 Earnings Call, Jul 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.31% | 606M | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-11.23% | 32.76B | |
+79.34% | 29.46B | |
-12.23% | 16.31B | |
+3.92% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- RBC Lifts Price Target on Avid Bioservices to $32 From $27, Calls Fiscal Q2 'Impressive Quarter for New Business Wins,' Keeps Outperform